SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.710.0%11:58 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (5567)9/16/1998 11:29:00 AM
From: Anthony Wong  Read Replies (2) of 9523
 
'Hype overshadowing need'
The Telegraph, 16 September 1998


A DOCTOR who worked on the Viagra project from its inception
in 1985 says the hype that has surrounded the drug has
overshadowed the real need among men who suffer impotence.

Dr Gill Samuels, Pfizer's director of science policy, said: "The NHS
spends œ12 million a year on erectile disfunction already, so the
Government's refusal to issue it on the NHS is difficult to
understand."

She said she has never seen a response from patients to equal the
letters Pfizer has received. One read: "This medication has had a
substantial positive effect on my life and marriage. It may be difficult
for someone who has not suffered impotence to comprehend the
effect of the condition on one's life. But the word 'devastating' comes
close."

Dr Samuels described the discovery of Viagra as a "great British
achievement" after the drug was pioneered by British scientists based
at Sandwich, Kent, with more than 1,500 people working on it over
the past 17 years. However she gave a warning: "There is a certain
amount of risk involved in sex due to cardiac workload and it is
important that patients are examined carefully by physicians before
receiving the drug." She said that the 69 deaths which had been
linked to Viagra had been thoroughly investigated.

Regarding the NHS, Dr Samuels said that her firm had been
discussing the price - now agreed at œ4.84 a tablet - for "several
months".

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News